Enzymatic vitreolysis with recombinant tissue plasminogen activator for vitreomacular traction

References

• ZdenekGKańskiJRetinal Detachment: A Colour Manual of Diagnosis and Treatment1995
   Google Scholar
• JaffeNSVitreous traction at the posterior pole of the fundus due to alterations in the vitreous posteriorTrans Am Acad Ophthalmol Otolaryngol1967716426526052820
   PubMedGoogle Scholar
• KańskiJClinical Ophthalmology2009705Polish edition
   Google Scholar
• BrownDJBishopPHamdiHKenneyMCCleavage of structural components of mammalian vitreous by endogenous matrix metalloproteinase-2Curr Eye Res1996154394458717491
   PubMed Web of Science ®Google Scholar
• WilliamESmiddyMDRonaldGMorphology, pathology and surgery of idiopathic vitreoretinal macular disorders. A reviewRetina19901042882962089546
   PubMed Web of Science ®Google Scholar
• GandorferARohlederMKampikAEpiretinal pathology of vitreomacular traction syndromeBr J Ophthalmol200286890290912140213
   PubMed Web of Science ®Google Scholar
• WangMYNguyenDHindoyanNSadunAASebagJVitreo-papillary adhesion in macular hole and macular puckerRetina20092964465019357556
   PubMed Web of Science ®Google Scholar
• CapponeAMacular surface disordersFocal Points: Clinical Modules for OphthalmologistsSan FranciscoAmerican Academy of Ophthalmology1996 module 4
   Google Scholar
• WilliamsRGChangSComarattaMRSimoniGDoes the presence of heparin and dexamethasone in the vitrectomy infusate reduce reproliferation in proliferative vitreoretinopathy?Graefes Arch Clin Exp Ophthalmol199623484965038858355
   PubMed Web of Science ®Google Scholar
• WiedemannPHilgersRDBauerPHeimannKAdjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin.Study GroupAm J Ophthalmol199812645505599780100
   PubMed Web of Science ®Google Scholar
• CharterisDGAylwardGWWongDA randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in management of established proliferative vitreoretinopathyOphthalmology2004111122240224515582080
   PubMed Web of Science ®Google Scholar
• WolfSSchönVMeierPWiedemannPSilicone oil-RMN3 mixture (“heavy silicone oil”) as internal tamponade for complicated retinal detachmentRetina200323333534212824833
   PubMed Web of Science ®Google Scholar
• CzajkaMPecoldK[The use of enzymes in vitreoretinal surgery]. Zastosowanie enzymów w chirurgii witreoretinalnejKlin Oczna200210415962 Polish12046313
   PubMedGoogle Scholar
• SebagJPharmacologic vitreolysis (editorial)Retina199818139502274
   PubMed Web of Science ®Google Scholar
• SebagJIs pharmacologic vitreolysis brewing?Retina20022211311884870
   PubMed Web of Science ®Google Scholar
• TripathiBJGeanonJDTripathiRCDistribution of tissue plazminogen activator in human and monkey eyes. An immunohistochemical studyOphthalmology19879411143414383120076
   PubMed Web of Science ®Google Scholar
• ImmonenIVaheriATommilaPSirénVPlasminogen activation in epiretinal membranesGraefes Arch Clin Exp Ophthalmol1996234116646698950585
   PubMed Web of Science ®Google Scholar
• KameiMEstafanousMLewisHTissue plasminogen activator in the treatment of vitreoretinal diseasesSemin Ophthalmol2000151445010749314
   PubMedGoogle Scholar
• JohnsonRNOlsenKRHernandezEIntravitreal tissue plasminogen activator treatment of experimental vitreous haemorrhageArch Ophthalmol19891078919042499298
   PubMedGoogle Scholar
• Heras-MuleroHGarcía-GómezPJSádaba-EcharriLMSalinas-AlamánAGarcía-LayanaATraumatic submacular hemorrhage treated with rt-PA and SF6Arch Soc Esp Oftalmol200782851752017717774
   PubMedGoogle Scholar
• KreplerKKrugerATittlMSturMWedrichAIntravitreal injection of tissue plasminogen activator and gas in subretinal hemorrhage caused by age-related macular degenerationRetina200020325125610872929
   PubMed Web of Science ®Google Scholar
• ChenSNHoCLKuoYHHoJDIntravitreous tissue plasminogen activator injection and pneumatic displacement in the management of submacular hemorrhage complicating scleral buckling proceduresRetina200121546046311642374
   PubMed Web of Science ®Google Scholar
• ChiselităDAntohiICioncaDMedvichiRCimpoeşuDThe use of tissue plasminogen activator in the post-operative treatment of fibrinoid uveitisOftalmologia2006502687216927762
   PubMedGoogle Scholar
• Oficjalska-MłyńczakJMarekJZając-PytrusHNiżankowskaMKoziorowskaMTkankowy aktywator plazminogenu w leczeniu błon włóknikowych po operacji zaćmyKlin Oczna19969864234259340414
   PubMedGoogle Scholar
• MurakamiTTakagiHKitaMIntravitreal tissue plasminogen activator to treat macular edema associated with branch retinal vein occlusionAm J Ophthalmol2006142231832016876516
   PubMed Web of Science ®Google Scholar
• WeizerJSFekratSIntravitreal tissue plasminogen activator for the treatment of central retinal vein occlusionOphthalmic Surg Lasers Imaging200334435035212875471
   PubMedGoogle Scholar
• KertesPJPeymanGAChouFMeffertSConwayMDThe use of tissue plasminogen activator in silicone oil-filled eyesCan J Ophthalmol199833128299513769
   PubMed Web of Science ®Google Scholar
• MacCumberMWMcCuenBW2ndTothCAFerronePJJaffeGJTissue plasminogen activator for preserving inferior peripheral iridectomy patency in eyes with silicone oilOphthalmology199610322692738594513
   PubMed Web of Science ®Google Scholar
• ZaltaAHSweeneyCPZaltaAKKaufmanAHIntracameral tissue plasminogen activator use in a large series of eyes with valved glaucoma drainage implantsArch Ophthalmol2002120111487149312427061
   PubMedGoogle Scholar
• TsuiIAirianiSWenAEl-SawyTFineHFMarisPJIntravitreal injection of tissue plasminogen activator as treatment for an occluded pars plana glaucoma tubeClin Ophthalmol20093919319668550
   PubMedGoogle Scholar
• HesseLNebelingBSchroederBHellerGKrollPInduction of posterior vitreous detachment in rabbits by intravitreal injection of tissue plasminogen activator following cryopexyExp Eye Res2000701313910644418
   PubMed Web of Science ®Google Scholar
• SonodaKHSakamotoTEnaidaHResidual vitreous cortex after surgical posterior vitreous separation visualized by intravitreous triamcinolone acetonideOphthalmology200411122623015019367
   PubMed Web of Science ®Google Scholar
• TachiNOginoNVitrectomy for diffuse macular edema in cases of diabetic retinopathyAm J Ophthalmol19961222582608694095
   PubMed Web of Science ®Google Scholar
• KiryuJKitaMTanabeTPars plana vitrectomy for cystoid macular edema secondary to sarcoid uveitisOphthalmology20011081140114411382643
   PubMed Web of Science ®Google Scholar
• TachiNHashimotoYOginoNVitrectomy for macular edema combined with retinal vein occlusionDoc Ophthalmol19999746546910896365
   PubMed Web of Science ®Google Scholar
• StefanssonENovackRLHatchellDLVitrectomy prevents retinal hypoxia in branch retinal vein occlusionInvest Ophthalmol Vis Sci1990312842892303330
   PubMed Web of Science ®Google Scholar
• Oficjalska-MlynczakJZajac-PytrusHMarekJNizankowskaMHTreatment of subretinal macular hemorrhages with intravitreous injections of tissue plasminogen activator and SF6 gasKlin Oczna20031053–414014614552171
   PubMedGoogle Scholar
• JaffeGGreenGAbramsGStability of recombinant tissue plasminogen activatorAm J Ophthalmol198910890912502019
   PubMed Web of Science ®Google Scholar
• SebagJAge-related changes in human vitreous structureGraefe’s Arch Clin Exp Ophthalmol198722589933583000
   PubMed Web of Science ®Google Scholar
• AznabayevMTAznabayevRAKazakbayevAGIskandartevRHVitreous surgery in childrenDoc Ophthalmol1994863813867835175
   PubMed Web of Science ®Google Scholar
• KameiMMisonoKLewisHA study of the ability of tissue plasminogen activator to diffuseinto the subretinal space after intravitreal injection in rabbitsAm J Ophthalmol1999128673974610612511
   PubMed Web of Science ®Google Scholar
• RiceTAInternal limiting membrane removal in surgery for full-thickness macular holesMadreperlaSAMc CuenBWIIMacular Hole, Pathogenesis, Diagnosis and TreatmentBostonButterworth Heinemann1998125146
   Google Scholar
• Castro NavarroJGonzalez-CastanoCMacular hole surgery with and without internal limiting membrane peelingArch Soc Esp Oftalmol200378315916412677493
   PubMedGoogle Scholar
• GandorferAElisabethMUlbigMWKampikAResolution of diabetic macular edema after surgical removal of the posteriori hyaloid and the inner limiting membraneRetina20002012613310783944
   PubMed Web of Science ®Google Scholar
• ChristensenUCKroyerKSanderBJorgensenTMLarsenMla CourMMacular morphology and visual acuity after macular hole surgery with or without internal limiting membrane peelingBr J Ophthalmol2010941414719692379
   PubMed Web of Science ®Google Scholar
• ParkSSMarcusDMDukerJSPosterior segment complications after vitrectomy for macular holeOphthalmology199510257757817777277
   PubMed Web of Science ®Google Scholar
• StalmansPDelaeyCMarcDIntravitreal injection of microplasmin for treatment of vitreomacular adhesion. Results of a prospective, randomized, sham-controlled phase II trial (The MIVI-IIT Trial)Retina2010301122112720616687
   PubMed Web of Science ®Google Scholar